Brian Hicks, writing for Angel Publishing’s Outsider Club, leads with “My Promise: In Three Short Words ‘BIG-TIME RICH’ (Plus a $15,000 Giveaway to Help You Build Your Fortune).”
The accompanying report is billed as “Our #1 Pick for 10X Potential,” pointing readers toward a little-known American uranium company tied to advanced-reactor fuel, nuclear batteries and a Department of Energy contract. The promotion adds a 300-second countdown and says the offer is limited to the first 150 sign-ups.
The stock is identified below. We’re highly confident in the match, at 89 out of 100.
What the promotion gave away
The history clue is unusually specific: roots in the Manhattan Project, a Cold War enrichment lineage and an American base. The pitch then narrows the field to a company involved in reactor fuel, with customers beyond the United States.
The strongest fingerprint is the October 2019 DOE agreement for HALEU production using a 16-centrifuge cascade at Piketon, Ohio. HALEU means high-assay, low-enriched uranium, the fuel grade many advanced-reactor designs require. That combination is hard to mistake.
The stock behind Our #1 Pick for 10X Potential
The company is Centrus Energy Corp. (NYSE: LEU).
Centrus’s October 31, 2019 SEC Form 8-K says its subsidiary, American Centrifuge Operating, entered into an agreement with the Department of Energy. Centrus’s announcement describes the roughly $115 million, three-year project to demonstrate HALEU production with a 16-centrifuge cascade at Piketon. That is the giveaway clue.
Centrus’s history page traces its lineage to the Oak Ridge uranium-enrichment enterprise developed during the Manhattan Project, while its corporate profile places headquarters in Bethesda, Maryland. The lineage needs one footnote: Centrus itself wasn’t formed until 2014, even though its predecessors operated Cold War-era enrichment plants.
Every claim, checked
The claim-by-claim check follows, matching the promotion’s language against Centrus’s history page, corporate profile, 2025 Form 10-K, the 2019 SEC filing, Department of Energy and Nuclear Regulatory Commission material, and current market data.
The distinction matters here. A supported fact stays supported; a dramatic upgrade gets marked as an overstatement rather than waved through because the underlying company is real.
| The promotion claims | Verdict | What we found |
|---|
| The company was little-known. | Checks out | LEU averaged about 884,000 shares a day and had a market capitalisation of roughly $3.56 billion, consistent with a niche, less-liquid stock rather than a household-name mega-cap. |
| The company was a small-cap stock. | Overstated | LEU's latest market capitalisation was about $3.56 billion, above the roughly $300 million-to-$2 billion range normally used for small-cap stocks, although the company may have fit that label when the promotion was published. |
Where the pitch outran the record
“The company was a small-cap stock.” — LEU's latest market capitalisation was about $3.56 billion, above the roughly $300 million-to-$2 billion range normally used for small-cap stocks, although the company may have fit that label when the promotion was published. “The company was 22 times smaller than Cameco Corp.” — The latest market figures put LEU's market capitalisation at about $3.56 billion and Cameco's at about $41.03 billion, making LEU roughly 11.5 times smaller, not 22 times. “The company has powered America's nuclear defense since the Cold War.” — Centrus's history page confirms that its predecessor operated Cold War-era enrichment plants and that the government enrichment enterprise began for defense purposes, but Centrus itself was not formed until 2014.
“The company produces fuel for large-scale reactors.” — Centrus's 2025 Form 10-K describes the segment as selling separative-work-unit components, uranium products and enriched uranium to utilities, which supports a reactor-fuel role but overstates the company as a producer of complete finished fuel.
Get AI research on any stock
Instant reports, daily intelligence, and an AI analyst in your pocket.
Get Started →About that deadline
The promotion attaches urgency to a 300-second countdown and the first 150 sign-ups. We received this campaign on one day only, July 31, 2026, so the record is too thin to judge whether that deadline rolls.
The clock is attached to the offer itself, not to a disclosed earnings date, regulatory decision or other company event. One day tells us what the promotion said; it doesn’t tell us how the countdown behaves over time.
Is it actually worth owning?
Centrus is a real nuclear-fuel company with a genuine HALEU project and a strategically important place in the advanced-reactor supply chain. But the current market value in this review is about $3.56 billion, which doesn’t fit the usual small-cap range of roughly $300 million to $2 billion. The claim that Centrus was 22 times smaller than Cameco also misses: the latest figures make it about 11.5 times smaller.
The bigger stretch is “nuclear batteries.” Centrus’s 2025 Form 10-K describes sales of separative-work-unit components, uranium products and enriched uranium to utilities in the United States, Japan, the Netherlands and other markets. That supports a reactor-fuel business, not the manufacture of complete finished fuel cells or batteries.
Centrus may deserve a serious look on its own merits, especially around HALEU production, government contracts, customer adoption and the cost of scaling enrichment. A 10X return, though, is not a filing fact, and a countdown doesn’t change the company’s valuation or execution risk. Read our full Centrus workup for the deeper financial and business review.
How confident are we? 89 out of 100. We identified Centrus Energy Corp. (LEU) from the promotion's own clues and checked 14 of its claims against filings, earnings calls, ownership records, market data and public reporting. This is our analysis, not the publisher's disclosure — we have no relationship with them.